US FDA clearance for Abbott's molecular diagnostic test for detection of chlamydia & gonorrhoea infections

Abbott announced that it has received 510(k) clearance from the US Food and Drug Administration to market a new, sensitive molecular diagnostic test and instrument to simultaneously detect two of the nation's most prevalent sexually transmitted diseases (STDs), gonorrhoea and chlamydia, including a new variant strain of chlamydia recently discovered in Sweden...............& more